ONCT
Oncternal Therapeutics Inc: Four Oncternal Employees Will Remain in a Part-Time Capacity in Connection With Exploration of Strategic Alternatives
时间：2024-11-15 06:09:13 市场： 美股 综合
Oncternal Therapeutics Inc: Announces Workforce Reduction Effective December 2, 2024
时间：2024-11-15 06:09:13 市场： 美股 综合
Oncternal Therapeutics : Workforce Reduction of About 10 Employees
时间：2024-09-13 05:04:46 市场： 美股 综合
Sector Update: Health Care Stocks Rise in Thursday Trading Health care stocks rose Thursday with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both up 0.4%.The iShares Biotechnology ETF (IBB) was little changed.In corporate news, Eli Lilly (LLY) shares gained 1.6%. The company said it's investing $1 billion to expand its manufacturing site in Limerick, Ireland, to increase production of biologic active ingredients, including those used for its treatment of early symptomatic Alzheimer's disease.Monopar Therapeutics (MNPR) shares surged 65% after it reported positive early data from a phase 1 trial of MNPR-101-Zr to treat multiple types of cancer.Moderna (MRNA) shares tumbled 12% after the company said it plans to cut research and development spending to save costs and prioritize the launch of new products in the pipeline.Oncternal Therapeutics' (ONCT) shares plunged 58% after the company decided to discontinue its clinical studies, all product development
时间：2024-09-13 04:02:47 市场： 美股 综合
Oncternal Therapeutics Shares Hit Record Low as Co to Scrap Studies, Explore Strategic Alternatives, Last Down 58.6% at $1.72
时间：2024-09-12 22:01:18 市场： 美股 综合
Oncternal Therapeutics Inc - Onct-534 Phase 1 Results Show No Clinically Meaningful Improvements
时间：2024-09-12 21:00:02 市场： 综合 美股
Oncternal Therapeutics Inc - to Explore Strategic Alternatives to Maximize Stockholder Value
时间：2024-09-12 21:00:02 市场： 综合 美股
Oncternal Therapeutics Announces Termination of Its Clinical Studies and Exploration of Strategic Alternatives
时间：2024-09-12 21:00:02 市场： 综合 美股
Oncternal Therapeutics Inc - One Death Reported in Onct-808 Trial Due to Shock Complications
时间：2024-09-12 21:00:02 市场： 综合 美股